US$ 24.48
microdosing compounded semaglutide GLP-1 Explained Microdosing Semaglutide: Weight Loss Plus
Description
Maximus is proud to introduce GLP-1 Microdosinga clinical, low-dose approach to weight optimization for high-performing men

Patients who reduced the frequency of GLP-1 dosing (from weekly to every other week) were able to maintain their weight loss and metabolic syndrome gains, as reported in this case series

Do not exceed recommended serving

See which tips earned top scores and which ones came with important caveats

View our FDA listing

Its dual mechanism as a GLP-1 receptor agonist provides powerful effects on both glycemic control and body weight regulation, with efficacy that exceeds previous pharmacological approaches
